$CRDO

3 Under-the-Radar AI Stocks Wall Street Is Missing

Credo Technology (CRDO) reported Q4 2026 revenue of $437M, up 157% YoY, with guidance for 80% YoY growth in 2027. Astera Labs (ALAB) saw Q2 2026 revenue of $392.4M, up 104% YoY, with Scorpio X series ramping ahead of schedule. Camtek (CAMT) reported Q2 2026 revenue of $133.24M, up 8% YoY, with a strong order book extending into 2027.

Original reporting
Published Aug 28, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 12:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
3 Under-the-Radar AI Stocks Wall Street Is Missing — source image
Decision brief

The 30-second read

$CRDOBullishMed
01

Why it matters

Each firm delivered earnings beats and forward guidance, providing fresh data points for traders targeting AI supply‑chain plays.

02

Market read

Earnings and guidance releases create immediate trading opportunities in the AI infrastructure niche.

03

What to watch

Potential supply‑chain disruptions in Israel for Camtek and foreign exchange risk for overseas customers.

Relevance 7/10Novelty 7/10Timing: ahead of September 2026 earnings season

Background

The article surveys three mid‑cap AI‑infrastructure companies that are often missed in mainstream AI hype.

Company-level read

Ticker impact

$CRDOBullishHigh confidence
Context

Credo Technology reported Q4 FY2026 results with 157% YoY revenue growth and raised FY2027 revenue guidance, a fresh earnings disclosure.

Expected impact

Potential price appreciation of 10-15% if guidance is sustained.

Evidence & confidence

Quarterly beat and forward guidance exceed consensus, indicating momentum.

$ALABBullishHigh confidence
Context

Astera Labs posted Q2 FY2026 results with record revenue and announced Scorpio X series volume production ahead of schedule.

Expected impact

Possible 8-12% rally on the news.

Evidence & confidence

Earnings beat and new product milestone provide fresh catalyst.

$CAMTBullishMedium confidence
Context

Camtek released Q2 2026 results showing record revenue and a large order backlog extending into 2027.

Expected impact

Likely 5-10% price gain as investors price in future bookings.

Evidence & confidence

Strong order intake but higher risk from regional exposure.

Market effects

Highlights growing demand for AI infrastructure components beyond GPUs, benefiting the broader semiconductor supply chain.

Positive for U.S. mid‑cap tech stocks and may lift related AI‑theme ETFs.

Signals continued global hyperscaler capex, supporting worldwide AI hardware demand.

Counterpoint

High customer concentration and elevated beta could lead to outsized downside if hyperscaler spending slows.

Key entities

  • Credo Technology

    Connectivity and optical components for AI data centers.

  • Astera Labs

    AI fabric switching and signal conditioning.

  • Camtek

    Advanced packaging inspection for HBM and chiplets.

Related articles

$CRDOMed

What's Going On With Credo Technology Stock on Thursday?

Credo Technology (CRDO) shares rose 4% in premarket trading on Thursday. The company launched its 224G-based ZeroFlap optical transceiver family for AI networking, a key step in its roadmap. Credo reported Q1 2027 revenue of $479M, beating estimates, with CEO Bill Brennan highlighting AI infrastructure as a growth driver. Analysts maintain a Buy rating with an average price target of $273.07.

$ALABMed

ALAB Stock Holds Support As High Valuation Tests Traders

Astera Labs Inc. (ALAB) stock rose 6.54% due to strong AI infrastructure demand. The company reported $392.4M in quarterly revenue, $153.1M in net income, and $67.2M in free cash flow. ALAB trades at 127x earnings and 37x sales, with a strong balance sheet but high valuation concerns. Traders are watching key price levels around $262–$265 and $272–$275.

$ALABMed

ALAB Broadens Leo Portfolio: Can It Stay Ahead of MRVL & CRDO?

Astera Labs (ALAB) reported record Q2 2026 revenue growth, driven by AI connectivity products. The company expanded its Leo CXL memory controller portfolio, gaining hyperscaler traction. Q3 2026 revenue is expected between $540M and $560M. Competitors Marvell (MRVL) and Credo (CRDO) are also advancing in AI connectivity. ALAB shares rose 51.8% YTD, with a forward P/S of 16.16X.

$CRDOMedAI 8/10

Credo vs. Broadcom: Which AI Connectivity Stock Is the Better Pick?

Credo (CRDO) and Broadcom (AVGO) are both benefiting from the AI infrastructure boom. Credo reported Q1 revenues of $479M, up 115% YoY, with strong growth in optical and AEC segments. Broadcom saw Q3 revenues of $29.59B, up 85.5% YoY, with AI semiconductors representing 56% of total revenue. Both companies show strong growth but face risks like customer concentration and execution challenges.

$ALABMed

Why Is Astera Labs Stock Down Today?

Astera Labs (NASDAQ: ALAB) shares dropped 10.1% on Sept. 14, 2026, after AI leaders called for slower AI development, threatening demand for its data-center networking products. The decline was steeper than the S&P 500's 0.3% and Nasdaq's 0.1% drops.

$ALABMed

Astera Labs’ Scorpio X Is Already in Volume Production. Citi Showed How Fast the Customer List Is Growing

Astera Labs (ALAB) announced its Scorpio X product line is in volume production and expects revenue growth, with customer engagements increasing. The company guided Q3 revenue to $540M-$560M. Shares dropped after missing S&P 500 inclusion. Analysts set a mid-target price of ~$715, citing potential total return of ~146%. Risks include customer concentration and valuation multiple compression.